Product NDC: | 68788-9703 |
Proprietary Name: | Clindamycin Hydrochloride |
Non Proprietary Name: | Clindamycin Hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; Clindamycin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68788-9703 |
Labeler Name: | Preferred Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065442 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130308 |
Package NDC: | 68788-9703-1 |
Package Description: | 14 CAPSULE in 1 BOTTLE (68788-9703-1) |
NDC Code | 68788-9703-1 |
Proprietary Name | Clindamycin Hydrochloride |
Package Description | 14 CAPSULE in 1 BOTTLE (68788-9703-1) |
Product NDC | 68788-9703 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20130308 |
Marketing Category Name | ANDA |
Labeler Name | Preferred Pharmaceuticals, Inc. |
Substance Name | CLINDAMYCIN HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |